Contract Awards Details
Ref No 21725993
Document

Contract Awards

Bidding

International Competitive Bidding

Contract Details

Delivery Of A Medicinal Product Containing The Active Substance Mirvetuximabum Soravtansinum Referred Under The B.50 Drug Program. Treatment Of Patients With Ovarian Cancer, Fallopian Tube Cancer Or Peritoneal Cancer. Delivery Of A Medicinal Product Containing The Active Substance Mirvetuximabum Soravtansinum Referred Under The B.50 Drug Program. Treatment Of Patients With Ovarian Cancer, Fallopian Tube Cancer Or Peritoneal Cancer.

Contract Completion *
Date 27 Jan 2026
* The estimated cost, values & dates are indicative only. Please read tender document for accurate information.
Client Address
Location Poland
More Information
Know More

FREE Trial Plan For All New Users!

Start your Business.
WhatsApp Chat